10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
MERCK & CO., INC. | |||
Ticker: MRK Fiscal Year: 2020 | |||
Consolidated Statement of Income | |||
Period Ending Dec 31, 2020 10-K (Filed: Feb 25, 2021) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Sales | $ 47,994 | 46,840 | 42,294 |
| Costs, Expenses and Other | |||
| Cost of sales | 15,485 | 14,112 | 13,509 |
| Selling, general and administrative | 10,468 | 10,615 | 10,102 |
| Research and development | 13,558 | 9,872 | 9,752 |
| Restructuring costs | 578 | 638 | 632 |
| Other (income) expense, net | (886) | 139 | (402) |
| Total costs, expenses and other | 39,203 | 35,376 | 33,593 |
| Income Before Taxes | 8,791 | 11,464 | 8,701 |
| Taxes on Income | 1,709 | 1,687 | 2,508 |
| Net Income | 7,082 | 9,777 | 6,193 |
| Less: Net Income (Loss) Attributable to Noncontrolling Interests | 15 | (66) | (27) |
| Net Income Attributable to Merck & Co., Inc. | 7,067 | 9,843 | 6,220 |
| Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) | 2.79 | 3.84 | 2.34 |
| Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) | 2.78 | 3.81 | 2.32 |
| External Links | |
| MERCK & CO., INC. (MRK) Fiscal Year 2020 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |